Research Topics
| Yu Ning WongSummaryAffiliation: Fox Chase Cancer Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Survival associated with treatment vs observation of localized prostate cancer in elderly menYu Ning Wong
Division of Population Science, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
JAMA 296:2683-93. 2006..Prostate-specific antigen screening has led to an increase in the diagnosis and treatment of localized prostate cancer. However, the role of active treatment of low- and intermediate-risk disease in elderly men is controversial...
Correlates of colorectal cancer screening adherence among men who have been screened for prostate cancerYu Ning Wong
Fox Chase Cancer Center, 333 Cottman Ave, Philadelphia, PA 19111, USA
J Cancer Educ 26:301-7. 2011..The prostate cancer screening encounter may represent a "teachable moment" to increase CRC screening rates...
The role of primary androgen deprivation therapy in localized prostate cancerYu Ning Wong
Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
Eur Urol 56:609-16. 2009..Primary androgen deprivation therapy (PADT) is frequently used as a sole modality of treatment in men with localized prostate cancer, despite a lack of clinical trial data supporting its use...
Cost implications of new treatments for advanced colorectal cancerYu Ning Wong
Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
Cancer 115:2081-91. 2009..The objective of the current study was to measure the cost implications of treatment with sequential regimens that include chemotherapy and/or monoclonal antibodies...
Role of androgen deprivation therapy for node-positive prostate cancerYu Ning Wong
Division of Population Science and Medical Science, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
J Clin Oncol 27:100-5. 2009..To determine the impact of adjuvant androgen deprivation therapy (ADT) for patients who have node-positive prostate cancer in the prostate-specific antigen (PSA) era...
Continued use of trastuzumab beyond disease progression in the national comprehensive cancer network: should we practice ahead of the evidence?Yu Ning Wong
Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, Pennsylvania 19111 2497, USA
Oncologist 16:559-65. 2011..Controlled clinical trials that establish a benefit from continued trastuzumab have been difficult to complete...
Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogramAlexander Kutikov
Department of Urological Oncology, Fox Chase Cancer Center, Temple University School of Medicine, Philadelphia, PA 19111, USA
J Clin Oncol 28:311-7. 2010....
Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomyAlexander Kutikov
Department of Urological Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
BJU Int 106:218-23. 2010....
Age, tumor size and relative survival of patients with localized renal cell carcinoma: a surveillance, epidemiology and end results analysisBenjamin J Scoll
Department of Urologic Oncology, Fox Chase Cancer Center, Temple University School of Medicine, Philadelphia, Pennsylvania 19111, USA
J Urol 181:506-11. 2009..We analyzed data from the SEER (Surveillance, Epidemiology and End Results) database to evaluate the relative survival of patients treated surgically for localized renal cell carcinoma as related to tumor size and patient age...
Histopathological characteristics of localized renal cell carcinoma correlate with tumor size: a SEER analysisJason Rothman
Department of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
J Urol 181:29-33; discussion 33-4. 2009..We determined whether a relationship exists between primary tumor size and histopathological features in cases of localized renal cancer...
Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancerMichael J Hassett
Center for Outcomes and Policy Research, Department of Medical Oncology, Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA
J Clin Oncol 30:2218-26. 2012..One of the first commercially available GEP tests, a 21-gene profile, was developed to estimate the benefit of adjuvant chemotherapy for hormone receptor-positive breast cancer (HR-positive BC)...
Advanced imaging modalities in early stage breast cancer: preoperative use in the United States Medicare populationMargaret L Crivello
Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
Ann Surg Oncol 20:102-10. 2013..Guidelines for breast cancer staging exist, but adherence remains unknown. This study evaluates patterns of imaging in early stage breast cancer usually reserved for advanced disease...
Competing risks of death in patients with localized renal cell carcinoma: a comorbidity based modelAlexander Kutikov
Department of Urological Oncology, Fox Chase Cancer Center, Temple University School of Medicine, Philadelphia, Pennsylvania 19111, USA
J Urol 188:2077-83. 2012..These factors must be considered against the benefits of treatment. We constructed a model of competing causes of death to help contextualize treatment trade-off analyses in patients with localized renal cell carcinoma...
Baseline renal function status limits patient eligibility to receive perioperative chemotherapy for invasive bladder cancer and is minimally affected by radical cystectomyDaniel Canter
Department of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
Urology 77:160-5. 2011..To evaluate the proportion of patients with muscle-invasive urothelial carcinoma (UC) who would be eligible to receive cisplatin-based chemotherapy before and after radical cystectomy based on renal function...
Pathologic concordance of sporadic synchronous bilateral renal massesJason Rothman
Department of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
Urology 72:138-42. 2008....
Understanding how out-of-pocket expenses, treatment value, and patient characteristics influence treatment choicesYu Ning Wong
Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, Pennsylvania 19111, USA
Oncologist 15:566-76. 2010..The influence of cost on the treatment choices of patients with life-threatening illness, such as cancer, is unknown...
Early stopping designs based on progression-free survival at an early time point in the initial cohortSamuel Litwin
Biostatistics Facility, Population Science Division, Fox Chase Cancer Center, 333 Central Avenue, Philadelphia, PA 19111, USA
Stat Med 26:4400-15. 2007..No distributional assumptions are needed other than the binomial, so the design provides rigorous power analysis for this type of study. Tables of optimal designs are supplied for a broad range of requirements...
Effects of increased cross-sectional imaging on the diagnosis and prognosis of adrenocortical carcinoma: analysis of the National Cancer DatabaseAlexander Kutikov
Department of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
J Urol 186:805-10. 2011..We assessed whether incidental screening due to imaging performed for other purposes has resulted in earlier detection or better outcomes in patients with adrenocortical carcinoma...
Adrenocortical carcinoma masquerading as a benign adenoma on computed tomography washout studyJay Simhan
Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
Urology 79:e19-20. 2012..We present a case of a 5-cm adrenal lesion with computed tomography washout characteristics consistent with a benign adenoma, which proved upon resection to be an adrenocortical carcinoma...
Chemotherapy use for hormone receptor-positive, lymph node-negative breast cancerMichael J Hassett
Department of Medical Oncology, Dana Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA
J Clin Oncol 26:5553-60. 2008....
Phase II trial of cetuximab with or without paclitaxel in patients with advanced urothelial tract carcinomaYu Ning Wong
University of Pennsylvania, Philadelphia, PA, USA
J Clin Oncol 30:3545-51. 2012..We conducted a randomized, noncomparative phase II study to measure the efficacy of cetuximab with or without paclitaxel in patients with previously treated urothelial cancer...
Preoperative delays in the US Medicare population with breast cancerRichard J Bleicher
Fox Chase Cancer Center, Philadelphia, PA 19111, USA
J Clin Oncol 30:4485-92. 2012....
Predicting growth of solid renal masses under active surveillancePaul L Crispen
Department of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
Urol Oncol 26:555-9. 2008..Here we evaluate factors that may help predict radiographic growth during observation...
Integration of prostate cancer clinical data using an ontologyHua Min
Fox Chase Cancer Center, Philadelphia, PA 19111, USA
J Biomed Inform 42:1035-45. 2009..As the results of the integration process, the semantic query language SPARQL is applied to perform the integrated queries across the two database systems based on PCO...
Sensitivity analysis to investigate the impact of a missing covariate on survival analyses using cancer registry dataBrian L Egleston
Biostatistics Facility, Fox Chase Cancer Center, Philadelphia, PA, USA
Stat Med 28:1498-511. 2009..We found that surgery was protective, but that the magnitude of the effect depended on assumptions about the relationship of grade with missingness...
Decrease in racial disparities in the staging evaluation for prostate cancer after publication of staging guidelinesNitya Abraham
New York University School of Medicine, New York, New York 10016, USA
J Urol 178:82-7; discussion 87. 2007....
